Search results
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 1 day agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 5 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 6 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 6 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 5 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 3 days agoDuring the last session, Moderna Inc (NASDAQ:MRNA)’s traded shares were 4.04 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock ...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 6 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 1 day agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 6 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 18 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...